Zusammenfassung
Eine kindliche Wachstumsstörung kann das erste und z. T. auch das einzige Symptom einer Vielzahl von Krankheiten sein. Dementsprechend komplex gestaltet sich oft die Diagnostik eines pathologischen Wachstums bei einem Kind. Untersuchungen auf hormonelle Störungen bei einem Kleinwuchs stellen daher nur eine Facette in einem großen Spektrum diagnostischer Maßnahmen dar, die bei der Ursachensuche zur Anwendung gelangen. Chronisch entzündliche Darmerkrankungen wie der Morbus Crohn oder chronische Malabsorptions- und Malassimilationsyndrome (Zöliakie) sind typische Beispiele nicht hormoneller Erkrankungen, die in einem frühen Erkrankungsstadium oder bei milder Ausprßgung bei dem betroffenen Kind allein durch eine Wachstumsstörung auffallen können. Zudem reagieren sßmtliche Hormonregelkreise beim Kind sensibel auf das Vorliegen somatischer oder psychischer Störungen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Amselem S., Duquesnoy P., Attree O. et al. (1989) Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321:989–995
Amselem S., Sobrier M.L., Duquesnoy P., Goossens M. (1991 a) Molecular Genetic of growth hormone resistance syndrome. Ann Endocrinol (Paris) 52:474–478
Amselem S., Sobrier M.L., Duquesnoy P. et al. (1991 b) Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. J Clin Invest 87:1098–1102
Asa S.L., Kovacs K. (1984) Functional morphology of the human fetal pituitary. Pathol Annu 19 Pt 1:275–315
Asa S.L., Kovacs K., Laszlo F.A., Domokos I., Ezrin C. (1986) Human fetal adenohypophysis. Histologic and immunocytochemieal analysis. Neuroendocrinology 43:308–316
Asa S.L., Kovacs K., Horvath E. et al. (1988) Human fetal adenohypophysis. Electron mieroscopic and ultrastructural immunocytochemical analysis. Neuroendocrinology 48:423–431
Ayling R.M., Ross R., Towner P. et al. (1997) A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat Genet 16:13–14
Bach I., Rhodes S.J., Pearse R.V.n. et al. (1995) P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 92:2720–2724
Backeljauw P.F., Underwood L.E. (1996) Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome-a clinical research center study. GHIS Collaborative Group. J Clin Endocrinol Metab 81:3312–3317
Baker J., Liu J.P., Robertson E.J., Efstratiadis A. (1993) Role of insulin-like growth factors in embryonie and postnatal growth. Cell 75:73–82
Bedford F.K., Christopherson K., Nachtigal M.W., Shen W.H., Julius D.J., Ingraham H.A. (1996) Molecular biology of pituitary development and disease. Horm Res 45:19–21
Bennett L.I., Weinberger H., Escamilla R., Margen S., Li C.H., Evans H.M. (1950) Failure of hypohyseal growth hormone to produce nitrogen storage in a girl with hypohyseal dwarfism. J Clin Endocrinol 10:492–495
Berg M.A., Argente J., Chernausek S. et al. (1993) Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet 52:998–1005
Bertherat J., Bluet Pajot M.T., Epelbaum J. (1995) Neuroendocrine regulation of growth hormone. Eur J Endocrinol 132:12–24
Binder G., Ranke M.B. (1995) Screening for growth hormone (GH) gene splice-site mutations in sporadie cases with severe isolated GH deficiency using ectopie transcript analysis. J Clin Endocrinol Metab 80:1247–1252
Blankenstein O., Kim C., Heinze H., Schneider A., Kentrup H., Pfßffle R. (1999) Genetic analysis of the growth hormone releasing hormone receptor in patients with hypopituitarism (abstract). Horm Res [Suppl 2] 51:33
Bluet-Pajot M.T., Epelbaum J., Gourdji D., Hammond C., Kordon C. (1998) Hypothalamic and hypophyseal regulation of growth hormone secretion. Cell Mol Neurobiol 18:101–123
Blum W.F., Ranke M.B. (1990) Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders. Horm Res [Suppl 4] 33:31–37
Blum W.F., Albertsson-Wikland K., Rosberg S., Ranke M.B. (1993) Serum levels of insulin-like growth factor I (IGFI) and IGF bin ding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76:1610–1616
Bowers C.Y., Aister D.K., Frentz J.M. (1992) The growth hormone-releasing activity of a synthetie hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 74:292–298
Braga S., Phillips J.A., Joss E., Schwarz H., Zuppinger K. (1986) Familial growth hormone deficiency resulting from a 7.6 kb deletion within the growth hormone gene cluster. Am J Med Genet 25:443–452
Brown M.R., Parks J.S., Adess M.E. et al. (1998) Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 49:98–102
Buckwalter M.S., Katz R.W., Camper S.A. (1991) Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 10:515–526
Carel J.C., Chaussain J.L., Chatelain P., Savage M.O. (1996) Growth hormone insensitivity syndrome (Laron syndrome): main characteristics and effects of IGFI treatment. Diabetes Metab 22:251–256
Chen E.Y., Liao Y.C., Smith D.H., Barrera-Saldana H.A., Gelinas R.E., Seeburg P.H. (1989) The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 4:479–497
Chen R.G., Shen Y.N., Yei J. et al. (1993) A comparative study of growth hormone (GH) and GH-releasing hormone( 1-29)-NH2 for stimulation of growth in children with GH deficiency. Acta Paediatr Suppl 388:32–36
Cogan J.D., Phillips J.A. 3rd (1998) Growth disorders caused by genetic defects in the growth hormone pathway. Adv Pediatr 45:337–361
Cogan J.D., Phillips J.A. 3rd, Sakati N., Frisch H., Schober E., Milner R.D. (1993) Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab 76:1224–1228
Cogan J.D., Ramel B., Lehto M. et al. (1995) A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency-a clinical research center study. J Clin Endocrinol Metab 80:3591–3595
Cogan J.D., Prince M.A., Lekhakula S. et al. (1997) A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 6:909–912
Cogan J.D., Wu W., Phillips J.A. 3rd et al. (1998) The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 83:3346–3349
Cohen L.E., Wondisford F.E., Salvatoni A. et al. (1995) A „hot spot” in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 80:679–684
Dattani M.T., Martinez-Barbera J.P., Thomas P.Q. et al. (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19:125–133
Dattani M., Brickmann J., Tyrrell R. et al. (1999) Novel mutations of Hesxl associated with septo-optic dysplasia in man (abstract). Horm Res [Suppl 2]51:32
de Zegher F., Pernasetti F., Vanhole C., Devlieger H., Van den Berghe G., Martial J.A. (1995) The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 80:3127–3l10
DeAlmeida V.I., Mayo K.E. (1998) Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. Mol Endocrinol 12:750–765
Dornene H., Krishnamurthi K., Eshet R. et al. (1993) Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology 133:675–682
Duquesnoy P., Sobrier M.L., Amselem S., Goossens M. (1991) Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc Natl Acad Sci USA 88:10272–10276
Edery M., Rozakis-Adcock M., Goujon L. et al. (1993) Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism. J Clin Invest 91:838–844
Feingold M., Shiere F., Fogeis H.R., Donaldson D. (1969) Rieger’s syndrome. Pediatrics 44:564–569
Fluck C., Deladoey J., Rutishauser K. et al. (1998) Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg->Cys at codon 120 (R120 C). J Clin Endocrinol Metab 83:3727–3734
Fofanova O., Takamura N., Kinoshita E. et al. (1998) Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 83:2601–2604
Fox S.R., Jong M.T., Casanova J., Ye Z.S., Stanley F., Samuels H.H. (1990) The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters. Mol Endocrinol 4:1069–1080
Freyd G., Kim S.K., Horvitz H.R. (1990) Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-11. Nature 344:876–879
Gage P.J., Camper S.A. (1997) Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 6:457–464
Gaylinn B.D., Harrison J.K., Zysk J.R., Lyons C.E., Lynch K.R., Thorner M.O. (1993) Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol 7:77–84
Gaylinn B.D., Kap Herr C von, Golden W.L., Thorner M.O. (1994) Assignment of the human growth hormone-releasing hormone receptor gene (GHRHR) to 7p14 by in situ hybridization. Genomics 19: 193–195
Gehring W.J., Hiromi Y. (1986) Homeotic genes and the homeobox. Annu Rev Genet 20:147–173
Gibbs C.J., Jr., Asher D.M., Brown P.W., Fradkin J.E., Gajdusek D.C. (1993) Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N Engl J Med 328:358–359
Gluckman P.D., Harding J.E. (1997) The physiology and pathophysiology of intrauterine growth retardation. Horm Res [Suppl 1]48:11–16
Goddard A.D., Covello R., Luoh S.M. et al. (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 333:1093–1098
Godfrey P., Rahal J.O., Beamer W.G., Copeland N.G., Jenkins N.A., Mayo K.E. (1993) GHRH receptor of little mice contains amissense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4:227–232
Godowski P.J., Leung D.W., Meacham L.R. et al. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:8083–8087
Goeddel D.V., Heyneker H.L., Hozumi T. et al. (1979) Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature 281:544–548
Hamilton J., Blaser S., Daneman D. (1998) MR imaging in idiopathic growth hormone deficiency. AJNR Am J Neuroradiol 19: 1609–1615
Hauffa B.P., Illig R., Torresani T., Stolecke H., Phillips J.A.d. (1989) Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA. Acta Endocrinol (Copenh) 121:609–614
He Y.A., Chen S.S., Wang Y.X., Lin X.Y., Wang D.F. (1990) A Chinese familial growth hormone deficiency with adeletion of 7.1 kb of DNA. J Med Genet 27:151–154
Hermesz E., Mackern S., Mahon K.A. (1996) Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke’s pouch of the mouse embryo. Development 122:41–52
Herr W., Sturm R.A., Clerc R.G. et al. (1988) The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 2:1513–1516
Hintz R.L. (1992) Untoward events in patients treated with growth hormone in the USA. Horm Res 38:44–49
Hintz R.L. (1995) The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment. J Clin Endocrinol Metab 80:2298–2301
Hintz R.L., Rosenfeld R.G., Wilson D.M. et al. (1982) Biosynthetic methionyl human growth hormones is biologically active in adult man. Lancet 1:1276–1279
Hirt H., Kirneiman J., Birnbaum M.J. et al. (1987) The human growth hormone gene locus: structure, evolution, and allelic variations. DNA 6:59–70
Hoppener J.W., de Pagter-Holthuizen P., Geurts van Kessel AH et al. (1985) The human gene encoding insulin-like growth factor I is located on chromosome 12. Hum Genet 69:157–160
Hummelink R., Sippell W.G., Benoit K.G., Danielson K., Faijerson Y. (1993) Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth. Acta PaediatrSuppl 388:23–27
Igarashi Y., Ogawa M., Kamijo T. et al. (1993) A new mutation causing inherited growth hormone deficiency: a compound heterozygote of a 6.7 kb deletion and a two base deletion in the third exon of the GH-1 gene. Hum Mol Genet 2:1073–1074
Ingraham H.A., Albert V.R., Chen R.P. et al. (1990a) A family of POU-domain and Pit1l tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol 52:773–791
Ingraham H.A., Chen R.P., Mangalam H.J. et al. (1988) A tissuespecific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519–529
Ingraham H.A., Flynn S.E., Voss J.W. et al. (1990b) The POUspecific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61:1021–1033
Irie Y., Tatsumi K., Ogawa M. et al. (1995) A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency. Endocr J 42:351–354
Jacobson E.M., Li P., Rosenfeld M.G., Aggarwal A.K.(1996) Crystallization and preliminary X-ray analysis of Pit-1 POU domain complexed to a 28 base pair DNA element. Proteins 24:263–265
Jacobson E.M., Li P., Leon-del-Rio A., Rosenfeld M.G., Aggarwal A.K. (1997) Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes Dev 11:198–212
Jacquemin P., Alsat E., Oury C. et al. (1996) The enhancers of the human placental lactogen B, A, and L genes: progressive activation during in vitro trophoblast differentiation and importance of the DF-3 element in determining their respective activities. DNA Cell Biol 15:845–854
Jones B.K., Monks B.R., Liebhaber S.A., Cooke N.E. (1995) The human growth hormone gene is regulated by a multi-component locus control region. Mol Cell Biol 15:7010–7021
Kaji H., Nose O., Tajiri H. et al. (1997) Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab 82:3705–3709
Kamijo T., Phillips J.A.d. (1992) Detection of molecular heterogeneity in GH-1 gene deletions by analysis of polymerase chain reaction amplification products. J Clin Endocrinol Metab 74:786–789
Kandemir N., Cila A., Besim A., Yordam N. (1998) Magnetic resonance imaging (MRI) findings in isolated growth hormone deficiency. Turk J Pediatr 40:385–392
Karin M., Theill L., Castrillo J.L., McCormick A., Brady H. (1990) Cell type specific expression of the growth hormone gene and its control by GHF-1. Nippon Naibunpi Gakkai Zasshi 66:1205–1220
Katakami H., Matsukura S. (1992) Regulation of growth hormone-releasing hormone gene expression and secretion. Nippon Naibunpi Gakkai Zasshi 68:1057–1072
Kelly P.A., Goujon L., Sotiropoulos A. et al. (1994) The GH receptor and signal transduction. Horm Res 42:133–139
Kirk J.M., Trainer P.J., Majrowski W.H., Murphy J., Savage M.O., Besser G.M. (1994) Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity. Clin Endocrinol (Oxf) 41:487–493
Kowarski A.A., Schneider J., Ben-Galim E., Weldon V.V., Daughaday W.H. (1978) Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 47:461–464
Kranzler J.H., Rosenbloom A.L., Martinez V., Guevara-Aguirre J. (1998) Normal intelligence with severe insulin-like growth factor I deficiency due to growth hormone receptor deficiency: a controlled study in a genetically homogeneous population. J Clin Endocrinol Metab 83:1953–1958
Lacey K.A., Parkin J.M. (1974) Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet 1:42–45
Lajara R., Galgani J.P., Jr., Dempsher D.P., Bier D.M., Rotwein P. (1990) Low prevalence of insulin-like growth factor-I gene mutations in human growth disorders. J Clin Endocrinol Metab 70:687–692
Lanes R., Carrillo E. (1994) Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group. J Pediatr Endocrinol 7:303–308
Laron Z. (1974) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sci 10:1247–1253
Laron Z., Pertzelan A., Mannheimer S. (1966) Genetic pituitary dwarfism with high serum concentation of growth hormone-a new inborn error of metabolism? Isr J Med Sci 2:152–155
Leidy J.W., Jr., Cugini C.D., Jr., Driscoll H.K., Chertow B.S. (1995) Time course of hypothalamic growth hormone-releasing hormone and somatostatin content in streptozoein diabetic rats: evidence for early changes in hypothalamic regulation. Brain Res 681:84–90
Lemaigre F.P., Courtois S.J., Durviaux S.M., Egan C.J., LaFontaine D.A., Rousseau G.G. (1989a) Analysis of cis-and trans-acting elements in the hormone-sensitive human somatotropin gene promoter. J Steroid Biochem 34:79–83
Lemaigre F.P., Courtois S.J., Lafontaine D.A., Rousseau G.G. (1989b) Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene. Eur J Biochem 181:555–561
Leung D.W., Spencer S.A., Cachianes G. et al. (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537–543
Li S., Crenshaw E.B.d., Rawson E.J., Simmons D.M., Swanson L.W., Rosenfeld M.G. (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528–533
Lifshitz F., Lanes R., Pugliese M. et al. (1992) Sustained improvement in growth veloeity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2. J Clin Endocrinol Metab 75:1255–1260
Lin S.C., Lin C.R., Gukovsky I., Lusis A.J., Sawchenko P.E., Rosenfeld M.G. (1993) Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208–213
Ling N., Zeytin F., Bohlen P. et al. (1985) Growth hormone releasing factors. Annu Rev Biochem 54:403–423
Lomasney J.W., Allen L.F., Lefkowitz R.J. (1995) Cloning and regulation of catecholamine receptor genes. In: Weintraub B.D. (ed) Molecular endocrinology. Raven Press, New York, pp 115–131
Magalhaes A.C., Uehara K.C., Iezzi D. et al. (1995) MRI of congenital pituitary insufficiency. Rev Hosp Clin Fac Med Sao Paulo 50:182–184
Maheshwari H.G., Silverman B.L., Dupuis J., Baumann G. (1998) Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J Clin Endocrinol Metab 83:4065–4074
Mangalam H.J., Albert V.R., Ingraham H.A. et al. (1989) A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 3:946–958
Masuda N., Watahiki M., Tanaka M. et al. (1988) Molecular cloning of cDNA encoding 20 kDa variant human growth hormone and the alternative splicing mechanism. Biochim Biophys Acta 949:125–131
Mayo K.E., Cerelli G.M., Lebo R.V., Bruce B.D., Rosenfeld M.G., Evans R.M. (1985) Gene encoding human growth hormone-releasing factor precursor:structure, sequence, and chromosomal assignment. Proc Natl Acad Sci USA 82:63–67
Mayo K.E., Miller T.L., DeAlmeida V., Zheng J., Godfrey P.A. (1996) The growth-hormone-releasing hormone receptor: signal transduction, gene expression, and physiological function in growth regulation. Ann NY Acad Sci 805: 184–203
Mitrakou A., Hadjidakis G., Raptis S., Bartsocas C.S., Souvatzoglou A. (1985) Heterogeneity of growth-hormone deficiency. Lancet 1:399–400
Muceielli M.L., Martinez S., Pattyn A., Goridis C., Brunet J.F. (1996) Ot1x2, an Otx-related homeobox gene expressed in the pituitary gland and in a restricted pattern in the forebrain. Mol cell Neurosci 8:258–271
Mullis P., Patel M., Brickell P.M., Brook C.G. (1990) Isolated growth hormone deficiency: analysis of the growth hormone (GH)-releasing hormone gene and the GH gene cluster. J Clin Endocrinol Metab 70:187–191
Mullis P.E., Akinei A., Kanaka C., Eble A., Brook C.G. (1992) Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatr Res 31:532–534
Musaro A., McCullagh K.J., Naya F.J., Olson E.N., Rosenthai N. (1999) IGF-1 induces skeletal myocyte hypertrophy through caleineurin in association with GATA-2 and NFATc1. Nature 400:581–585
Netchine I., Talon P., Dastot F., Vitaux F., Goossens M., Amselern S. (1998) Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. J Clin Endocrinol Metab 83:432–436
Neyzi O, Yordam N., Ocal G. et al. (1993) Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone. Acta Paediatr Suppl 388:16–22
Nishi Y., Hamamoto K., Kajiyama M. et al. (1993) Treatment of isolated growth hormone deficiency type IA due to GH-I gene deletion with recombinant human insulin-like growth factor I. Acta Paediatr 82:983–986
Ohta K., Nobukuni Y., Mitsubuchi H. et al. (I992a) Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 189:851–855
Ohta K., Nobukuni Y., Mitsubuchi H. et al. (I992b) Characterization of the gene encoding human pituitary-specific transcription factor, Pit-1. Gene 122:387–388
Parks J.S., Tenore A., Bongiovanni A.M., Kirkland R.T. (1978) Familial hypopituitarism with large sella turcica. N Engl J Med 298:698–702
Parks J.S., Adess M.E., Brown M.R. (1997) Genes regulating hypothalamic and pituitary development. Acta Paediatr Suppl 423:28–32
Pellegrini-Bouiller I., Belicar P., Barlier A. et al. (1996) A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 81:2790–2796
Perez Jurado L.A., Phillips J.A.r., Francke U. (1994a) Exclusion of growth hormone (GH)-releasing hormone gene mutations in familial isolated GH deficiency by linkage and single strand conformation analysis. J Clin Endocrinol Metab 78:622–628
Perez Jurado L.A., Phillips J.A.r., Summar M.L. et al. (1994b) Genetic mapping of the human growth hormone-releasing factor gene (GHRF) using two intragenic polymorphisms detected by PCR amplification. Genomics 20:132–134
Petersenn S., Rasch A.C., Heyens M., Schulte H.M. (1998) Structure and regulation of the human growth hormone-releasing hormone receptor gene. Mol Endocrinol 12:233–247
Pfßffle R.W., DiMattia G.E., Parks J.S. et al. (1992) Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118–1121
Pfßffle R.W., Parks J.S., Brown M.R., Heimann G. (1993) Pit-1 and pituitary function. J Pediatr Endocrinol 6:229–233
Pfßffle R.W., Kim C., Otten B. et al. (1996) Pit-1: clinical aspects. Horm Res 45:25–28
Pfßffle R.W., Martinez R., Kim C. et al. (1997) GH and TSH deficiency. Exp Clin Endocrinol Diabetes [Suppl 4] 105:1–5
Pfßffle R.W., Kim C., Wüller S. et al. (1998) Two Prop-1 mutations are prevalent among patients with combined pituitary hormone deficiency. Horm Res [Suppl 3] 50:10
Phillips J.A. (1995) Inherited defects in growth hormone synthesis and action. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D. (eds) The metabolie basis of inherited disease. McGraw-Hill, New York, pp 3023–3044
Phillips J.A.r., Cogan J.D. (1994) Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. J Clin Endocrinol Metab 78:11–16
Procter A.M., Phillips J.A., 3rd, Cooper D.N. (1998) The molecular Genetics of growth hormone deficiency. Hum Genet 103:255–272
Raben M.S. (1958) Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 18:901–903
Radoviek S., Nations M., Du Y., Berg L.A., Weintraub B.D., Wondisford F.E. (1992) A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 257:1115–1118
Raiti S. (1986) The national hormone and pituitary program (NHPP) historieal perspective. Acta Endocrinol Suppl 279:66–70
Ranke M.B. (1996) Growth hormone stimulation tests. In: Ranke M.B. (ed) Diagnosties of endocrine function in children and adolescents. J&#amp;J im Barth, Mannheim Heidelberg Leipzig, pp 134–148
Ranke M.B., Dowie J. (1999) KIGS and KIMS as tools for evidence-based medicine. Horm Res 51:83–86
Ranke M.B., Wilton P. (1994) Adverse events during treatment with recombinant insulin-like growth factor I in patients with growth hormone insensitivity. Acta Paediatr Suppl 399:143–145
Rao V.V., Loftler C., Schnittger S., Hansmann I. (1991) The gene for human growth hormone-releasing factor (GHRF) maps to or near chromosome 20p12. Cytogenet Ceil Genet 57:39–40
Rinderknecht E., Humbel R.E. (1978a) The amino acid sequence of human insulin-like growth factor land its structural homology with proinsulin. J Biol Chem 253:2769–2776
Rinderknecht E., Humbel R.E. (1978b) Primary structure of human insulin-like growth factor II. FEBS Lett 89:283–286
Rogers P.C., Komp D., Rogol A., Sabio H. (1977) Possible effects of growth hormone on development of acute lymphoblastic leukaemia. Lancet 2:434–435
Rona R.J., Tanner J.M. (1977) Aetiology of idiopathic growth hormone deficiency in England and Wales. Arch Dis Child 52:197–208
Rosenbloom A.L., Guevara Aguirre J., Rosenfeld R.G., Fielder P.J. (1990) The little women of Loja-growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 323:1367–1374
Rosenbloom A.L., Guevara-Aguirre J., Berg M.A., Francke U. (1998) Stature in Ecuadorians heterozygous for growth hormone receptor gene E180 spliee mutation does not differ from that of homozygous normal relatives. J Clin Endocrinol Metab 83:2373–2375
Rosenbloom A.L., Almonte A.S., Brown M.R., Fisher D.A., Baumbach L., Parks J.S. (1999) Clinical and biochemieal phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 84:50–57
Rosenfeld R.G. (1997) Is growth hormone deficiency a viable diagnosis? J Clin Endocrinol Metab 82:349–351
Rosenfeld R.G., Wilson D.M., Dollar L.A., Bennett A., Hintz R.L. (1982) Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab 54:1033–1038
Sadeghi-Nejad A., Senior B. (1974) Autosomal dominant transmission of isolated growth hormone deficiency in iris-dental dysplasia (Rieger’s syndrome). J Pediatr 85:644–648
Salmon W.D., Daughaday W.H. (1957) Hormonally controHed serum factor whieh stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825
Salvatori R., Hayashida C.Y., Aguiar-Oliveira M.H. et al. (1999) Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab 84:917–923
Sanchez J.E., Perera E., Baumbach L., Cleveland W.W. (1998) Growth hormone receptor mutations in children with idiopathie short stature. J Clin Endocrinol Metab 83: 4079–4083
Savage M.O., Korbonits M., Grossman A.B. (1996) Clinical value of neuropeptides GHRH and GHRP. Arch Pediatr 3:148s–150s
Schneid H., Seurin D., Le Bouc Y. (1991) Pathology of the growth and abnormalities of IGF genes. Ann Endocrinol 52:479–482
Semina E.V., Reiter R., Leysens N.J. et al. (1996) Cloning and characterization of a novel bieoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 14:392–399
Semina E.V., Reiter R.S., Murray J.C. (1997) Isolation of a new homeobox gene belonging to the Pitx/Rieg family: expression during lens development and mapping to the aphakia region on mouse chromosome 19. Hum Mol Genet 6:2109–2116
Sheng H.Z., Zhadanov A.B., Mosinger B., Jr. et al. (1996) Specification of pituitary ceil lineages by the LIM homeobox gene Lhx3. Science 272:1004–1007
Simmons D.M., Voss J.W., Ingraham H.A. et al. (1990) Pituitary cell phenotypes involve ceil-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 4:695–711
Simon P., Decoster C., Brocas H., Schwers J., Vassart G. (1986) Absence of human chorionie somatomammotropin during pregnancy associated with two types of gene deletion. Hum Genet 74:235–238
Sjogren K., Liu J.L., Blad K. et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088–7092
Sornson M.W., Wu W., Dasen J.S. et al. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327–333
Spencer S.A., Hammonds R.G., Henzel W.J., Rodriguez H., Waters M.J., Wood W.I. (1988) Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence. J Biol Chem 263:7862–7867
Stahnke N. (1992) Leukemia in growth-hormone-treated patients: an update, 1992. Horm Res 38:56–62
Stahnke N., Zeisel H.J. (1989) Growth hormone therapy and leukaemia. Eur J Pediatr 148:591–596
StaHings-Mann M.L., Ludwiczak R.L., Klinger K.W., Rottman F. (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci USA 93:12394–12399
Steendijk R. (1980) Diagnostic and aetiologic features of idiopathic and symptomatic growth hormone deficiency in the Netherlands. A survey of 176 children. Helv Paediatr Acta 35:129–139
Steinfelder H.J., Hauser P., Nakayama Y. et al. (1991) Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormone-inhibitory element. Proc Natl Acad Sci USA 88:3130–3134
Steinfelder H.J., Radovick S., Mroczynski M.A. et al. (1992) Role of a pituitary-specific transcription factor (pit-1/GHF-1) or a closely related protein in cAMP regulation of human thyrotropin-beta subunit gene expression. J Clin Invest 89:409–419
Sussenbach J.S. (1989) The gene structure of the insulin-like growth factor family. Prog Growth Factor Res 1:33–48
Takahashi Y., Kaji H., Okimura Y., Goji K., Abe H., Chihara K. (1996) Brief report: short stature caused by a mutant growth hormone. N Engl J Med 334:432–436
Takahashi Y., Shirono H., Arisaka O. et al. (1997) Biologically inactive growth hormone caused by an amino acid substitution. J Clin Invest 100: 1159–1165
Tatsumi K., Miyai K., Notomi T. et al. (1992) Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1:56–58
Thomas P., Beddington R. (1996) Anterior primitive endoderm may be responsible for patterning the anterior neural plate in the mouse embryo. Curr Biol 6:1487–1496
Thorner M.O., Vance M.L., Horvath E., Kovacs K. (1992) The anterior pituitary. In: Wilson J.D., Foster D.W. (eds) Textbook of endocrinology. Saunders, Philadelphia, pp 201–310
Thorner M., Rochiccioli P., Colle M. et al. (1996) Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab 81:1189–1196
Tillmann V., Buckler J.M., Kibirige M.S. et al. (1997) Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 82:531–535
Treisman J., Harris E., Desplan C. (1991) The paired box encodes a second DNA-binding domain in the paired homeo domain protein. Genes Dev 5:594–604
Underwood L.E., Voina S.J., Van Wyk J.J. (1974) Restoration of growth by human growth hormone in hypopituitary dwarfs immunized by other human growth hormone preparations: clinical and immunological studies. J Clin Endocrinol Metab 38:288–297
Valenta L.J., Sigel M.B., Lesniak M.A. et al. (1985) Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med 312:214–217
Vimpani G.V., Vimpani A.F., Lidgard G.P., Cameron E.H., Farquhar J.W. (1977) Prevalence of severe growth hormone deficiency. BMJ 2:427–430
Vnencak-Jones C.L., Phillips J.A.d., Chen E.Y., Seeburg P.H. (1988) Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci USA 85:5615–5619
Wagner J.K., Eble A., Hindmarsh P.C., Mullis P.E. (1998) Prevalence of human GH-l gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 43:105–110
Wajnrajch M.P., Gertner J.M., Harbison M.D., Chua S.C., Jr., Leibel R.L. (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 12:88–90
Walker J.L., Crock P.A., Behncken S.N. et al. (1998) A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue. J Clin Endocrinol Metab 83: 2554–2561
Ward L., Chavez M., Huot C. et al. (1998) Severe congenital hypopituitarism with low prolactin levels and age-dependent anterior pituitary hypoplasia: a clue to a PIT-1 mutation. J Pediatr 132:1036–1038
Way J.C., Chalfie M. (1988) Mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans. Cell 54:5–16
Wilton P., Wallstrom A. (1991) An overview of the diagnoses in the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 379:93–98
Wojcik J., Berg M.A., Esposito N. et al. (1998) Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor. J Clin Endocrinol Metab 83:4481–4489
Woods K.A., Camacho-Hubner C., Savage M.O., Clark A.J. (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1363–1367
Woods K.A., Dastot F., Preece M.A. et al. (1997) Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 82:3529–3535
Wu W., Cogan J.D., Pfaffle R.W. et al. (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18:147–149
Wurzel J.M., Parks J.S., Herd J.E., Nielsen P.V. (1982) A gene deletion is responsible for absence of human chorionic somatomammotropin. DNA 1:251–257
Youlton R. (1994) Growth hormone gene deletion: results of treatment with recombinant human insulin-like growth factor I. Acta Paediatr Suppl 399:150–151
Zhadanov A.B., Bertuzzi S., Taira M., Dawid I.B., Westphal H. (1995a) Expression pattern of the murine LIM dass homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 202:354–364
Zhadanov A.B., Copeland N.G., Gilbert D.J., Jenkins N.A., Westphal H. (1995 b) Genomic structure and chromosomal localization of the mouse LIM/homeobox gene Lhx3. Genomics 27:27–32
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Pfäffle, R., Blankenstein, O. (2000). Hormonelle Wachstumsstörungen. In: Ganten, D., Ruckpaul, K. (eds) Monogen bedingte Erbkrankheiten 2. Handbuch der Molekularen Medizin, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57044-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-57044-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62996-9
Online ISBN: 978-3-642-57044-5
eBook Packages: Springer Book Archive